Rowe R, Sheskey P, Quinn M
A single 4ml dose must be diluted with 500-1000ml of standard IV fluid (dextrose or saline) and administered via intravenous infusion by a healthcare professional, typically once daily
For laboratory and in-vitro research use only
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy
Castillo EJ, Delgado-Aros S, Camilleri M, Burton D, Stephens D, O'Connor-Semmes R, et al
Cagrilintide in the Broader Peptide Landscape The metabolic peptide field has expanded dramatically, with various compounds targeting different aspects of metabolism: GLP-1 agonists (semaglutide, liraglutide) Single incretin pathway Dual agonists (tirzepatide) GIP + GLP-1 pathways Amylin analogues (cagrilintide) Amylin pathway Triple agonists (retatrutide) GIP + GLP-1 + Glucagon Metabolic modulators (5-Amino-1MQ) NNMT inhibition Each class offers unique mechanisms and potential applications in metabolic research